| Literature DB >> 25056906 |
Maria Andree1, Jens M Seeger1, Stephan Schüll1, Oliver Coutelle1, Diana Wagner-Stippich1, Katja Wiegmann2, Claudia M Wunderlich3, Kerstin Brinkmann1, Pia Broxtermann1, Axel Witt1, Melanie Fritsch1, Paola Martinelli4, Harald Bielig2, Tobias Lamkemeyer5, Elena I Rugarli4, Thomas Kaufmann6, Anja Sterner-Kock7, F Thomas Wunderlich3, Andreas Villunger8, L Miguel Martins9, Martin Krönke1, Thomas A Kufer2, Olaf Utermöhlen10, Hamid Kashkar11.
Abstract
The X-linked inhibitor of apoptosis protein (XIAP) is a potent caspase inhibitor, best known for its anti-apoptotic function in cancer. During apoptosis, XIAP is antagonized by SMAC, which is released from the mitochondria upon caspase-mediated activation of BID. Recent studies suggest that XIAP is involved in immune signaling. Here, we explore XIAP as an important mediator of an immune response against the enteroinvasive bacterium Shigella flexneri, both in vitro and in vivo. Our data demonstrate for the first time that Shigella evades the XIAP-mediated immune response by inducing the BID-dependent release of SMAC from the mitochondria. Unlike apoptotic stimuli, Shigella activates the calpain-dependent cleavage of BID to trigger the release of SMAC, which antagonizes the inflammatory action of XIAP without inducing apoptosis. Our results demonstrate how the cellular death machinery can be subverted by an invasive pathogen to ensure bacterial colonization.Entities:
Keywords: SMAC; Shigella; XIAP; inflammation; mitochondria
Mesh:
Substances:
Year: 2014 PMID: 25056906 PMCID: PMC4282505 DOI: 10.15252/embj.201387244
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598